• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

BioCorRx

BioCorRx announces senior management changes

March 3, 2020 By Sean Whooley

BioCorRx (OTC:BICX) yesterday announced the promotions of Lourdes Felix to president and Tom Welch to executive VP of the company, effective immediately. Felix is set to retain her role as CFO and a member of the board of directors, while Welch departs his previous post as VP of operations at Anaheim, Calif.-based BioCorRx. According to a […]

Filed Under: Business/Financial News, Weight loss Tagged With: BioCorRx, Personnel Moves

Louisiana prisoners to get non-FDA-approved BioCorRx implant

May 8, 2019 By Nancy Crotti

BioCorRx (OTC:BICX) has begun a controversial pilot program to provide soon-to-be-released Louisiana prison inmates an opioid addiction treatment implant that has not been approved by the FDA. The pilot, announced last week, has drawn praise from corrections officials and concern from prisoner advocates and some medical professionals, according to a report in The Advocate, a Baton Rouge, La. newspaper. Ten […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, News Well Tagged With: BioCorRx, FDA, National Institutes of Health (NIH)

BioCorRx wins $5.6m grant for sustained release naltrexone implant

January 28, 2019 By Sarah Faulkner

BioCorRx (OTC:BICX) announced this month that it won a two-year grant from the NIH’s National Institute on Drug Abuse to support the development of its sustained release naltrexone implant for the treatment of opioid use disorder. The grant includes $2.8 million for Feb. 1, 2019 to Jan. 31, 2020, followed by $2.8 million for the second […]

Filed Under: Drug-Device Combinations, Funding Roundup, Implants, Pharmaceutical, Wall Street Beat Tagged With: BioCorRx

Anthem exec chairman joins Proteus board | Personnel Moves – Feb. 26, 2018

February 26, 2018 By Sarah Faulkner

Proteus Digital Health announced earlier this month that Anthem‘s (NYSE:ANTM) executive chairman, Joseph Swedish, joined the company’s board of directors. Swedish served as Anthem’s president & chief executive from 2013 until he was appointed executive chairman in 2018. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Aerie Pharmaceuticals, Allergan, Anthem Inc., BioCorRx, BrainStorm Cell Therapeutics Inc., Chrono Therapeutics, InfuSystem, Proteus Digital Health, Reva Medical Inc.

BioCorRx inks deal with Nat’l Institute on Drug Abuse

November 15, 2017 By Sarah Faulkner

BioCorRx (OTC:BICX) said today that it inked a confidentiality agreement with the National Institute on Drug Abuse, which will allow the group to share information and potentially work together on R&D and commercialization of BioCorRx’s therapies for opioid use disorder. The National Institutes of Health division has also agreed to participate as an observer at the […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Implants, Pharmaceutical, Regulatory/Compliance, Research & Development, Wall Street Beat Tagged With: BioCorRx, National Institutes of Health (NIH)

BioCorRx partners with virtual reality center for naltrexone implant study

June 1, 2017 By Sarah Faulkner

BioCorRx (OTC:BICX) said today that it partnered with the Virtual Reality Medical Center to conduct a study on the company’s long-lasting naltrexone implant. BioCorRx’s recovery program consists of a long-lasting implant that delivers an opioid antagonist, naltrexone, which reduces physical cravings for alcohol and opioids. The recovery service also has a counseling program specifically designed […]

Filed Under: Clinical Trials, Drug-Device Combinations, Implants, Pharmaceutical, Wall Street Beat Tagged With: BioCorRx

BioCorRx to meet with the FDA for injectable, sustained-release opioid addiction therapy

May 25, 2017 By Sarah Faulkner

BioCorRx (OTC:BICX) said today that the FDA has granted the anti-addiction developer a pre-investigational new drug meeting, scheduled for Sept. 19. The Anaheim, Calif.-based company said it is slated to review the development and marketing plan for BICX101, an injectable, sustained-release formulation of naltrexone as a therapy for opioid addiction and alcohol use disorders. Get […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: BioCorRx

BioCorRx launches R&D program for anti-addiction naltrexone drug-device combo

July 14, 2016 By Fink Densford

Anti-addiction developer BioCorRx said today it launched a research & development initiative as it seeks FDA approval for its naltrexone implant designed to treat opioid and alcohol addictions. If you have problem with addictions then read this blog. The implant slowly releases naltrexone, a non-addictive opioid antagonist that can reduce physical cravings and block some […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: BioCorRx

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS